DR. REDDY'S LABORATORIES LIMITED Company Dr. Reddy's Laboratories Limited NSE India S.E.
Equities
DRREDDY
INE089A01023
Pharmaceuticals
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6,219 INR | +4.50% |
|
+4.39% | +7.26% |
| 12:39pm | Nestle India Reports Rise in Quarterly Profit, Announces JV With Dr. Reddy's Laboratories | DJ |
| 12:36pm | Banking Stocks Lift Indian Equities Higher | MT |
Business Summary
- sales of generic medications (79.9%): brand-name or generic prescription medications and OTC medicines;
- sales of active ingredients (15.7%). The group also supplies customized pharmaceutical services;
- other (4.4%): sales of generic biopharmaceutical products, development of molecular agents, etc.
Net sales are distributed geographically as follows: India (18.8%), the United States (45%), Russia (9.9%) and other (26.3%).
Number of employees: 25,863
Sales per Business
| INR in Million | 2022 | Weight | 2023 | Weight | Delta |
|---|---|---|---|---|---|
Global Generics
86.9
%
| 179,170 | 83.6 % | 213,768 | 86.9 % | +19.31% |
Pharmaceutical Services and Active Ingredients
11.8
%
| 30,740 | 14.3 % | 29,069 | 11.8 % | -5.44% |
Others
1.2
%
| 2,870 | 1.3 % | 3,042 | 1.2 % | +5.99% |
Sales per region
| INR in Million | 2022 | Weight | 2023 | Weight | Delta |
|---|---|---|---|---|---|
United States
43.4
%
| 80,564 | 37.6 % | 106,683 | 43.4 % | +32.42% |
Others
27.4
%
| 68,962 | 32.2 % | 67,469 | 27.4 % | -2.16% |
India
20.5
%
| 43,986 | 20.5 % | 50,499 | 20.5 % | +14.81% |
Russia
8.6
%
| 20,879 | 9.7 % | 21,228 | 8.6 % | +1.67% |
Managers
| Managers | Title | Age | Since |
|---|---|---|---|
Erez Israeli
CEO | Chief Executive Officer | 57 | 18-04-01 |
Parag Agarwal
DFI | Director of Finance/CFO | - | 20-11-01 |
| Chairman | 56 | 93-01-17 | |
Gunupati Prasad
CHM | Chairman | 63 | 86-04-07 |
B. Phanimitra
CTO | Chief Tech/Sci/R&D Officer | - | 23-07-31 |
K. Randhir Singh
CMP | Compliance Officer | - | 22-03-16 |
Archana Bhaskar
IRO | Public Communications Contact | 57 | 17-05-31 |
Amith Agarwal
IRC | Investor Relations Contact | - | - |
Jayanth Sridhar
PRN | Corporate Officer/Principal | - | - |
Vivek Mittal
LAW | General Counsel | - | 21-04-30 |
Members of the board
| Members of the board | Title | Age | Since |
|---|---|---|---|
Gunupati Prasad
CHM | Chairman | 63 | 86-04-07 |
| Chairman | 56 | 93-01-17 | |
Kalpana Morparia
BRD | Director/Board Member | 73 | 07-06-04 |
Shikha Sharma
BRD | Director/Board Member | 64 | 19-01-30 |
Leo Puri
BRD | Director/Board Member | 63 | 18-10-24 |
Claudio Albrecht
BRD | Director/Board Member | - | 23-05-09 |
Arun M. Kumar
BRD | Director/Board Member | 72 | 22-07-31 |
Sanjiv Mehta
BRD | Director/Board Member | 63 | Dec. 28 |
| Director/Board Member | 64 | 22-01-06 | |
Alpna Seth
BRD | Director/Board Member | 60 | 23-09-18 |
Share class
| Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
|---|---|---|---|---|---|
| Stock A | 1 | 166,874,039 | 152,715,641 ( 91.52 %) | 345,564 ( 0.2071 %) | 91.52 % |
Company contact information
Dr. Reddy's Laboratories Ltd.
Door No. 8-2-337 Road No. 3
500034, Hyderabad
+91 40 4900 2900
http://www.drreddys.com
Group companies
| Name | Category and Sector |
|---|---|
Aurigene Discovery Technologies Ltd.
 Aurigene Discovery Technologies Ltd. BiotechnologyHealth Technology Aurigene Discovery Technologies Ltd. operates as biotechnology company. It offers research services such as integrated research and stand-alone research. The company is headquartered in Bangalore, India. |
Biotechnology
|
Dr. Reddy's Laboratories SA
 Dr. Reddy's Laboratories SA Pharmaceuticals: MajorHealth Technology Part of Dr. Reddy's Laboratories Ltd., Dr. Reddy's Laboratories SA is a Swiss company that develops, manufactures and sells pharmaceutical products. The private company is based in Basel, Switzerland. |
Pharmaceuticals: Major
|
Aurigene Pharmaceutical Services Ltd.
 Aurigene Pharmaceutical Services Ltd. BiotechnologyHealth Technology Aurigene Pharmaceutical Services Ltd. is a contract research, development, and manufacturing organization. It offer integrated and standalone services for medicinal chemistry, biology, preclinical services, DMPK studies, development, and manufacturing for clinical phase I-III programs. The company is headquartered in Bangalore, India. |
Biotechnology
|
Sector
Sales per Business
Sales per region
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +25.61% | 660B | |
| +22.75% | 562B | |
| -5.24% | 358B | |
| +16.49% | 322B | |
| +8.28% | 297B | |
| +12.79% | 219B | |
| -9.61% | 196B | |
| +6.39% | 199B | |
| -8.75% | 149B |
- Stock Market
- Equities
- DRREDDY Stock
- DRREDDY Stock
- Company Dr. Reddy's Laboratories Limited
